Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{161005,
        author = {Manoj Rajaram Patil and Lokesh Kothari and Atish Mundada},
        title = {An Overview of the New Drug Submission and Approval Process for Canada},
        journal = {International Journal of Innovative Research in Technology},
        year = {},
        volume = {10},
        number = {2},
        pages = {310-315},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=161005},
        abstract = {Health Canada is a 9th largest growing pharmaceutical market in the world. The Health Canada is the regulatory Authority of Canada that works under department of Minister of Health. Health Canada is responsible to approve the New Pharmaceutical Drug in Canada under the Food and Drug Branch with applicable Food and Drug Act and its Regulations. The health Canada is also responsible for approval or rejection of the various types of applications related to drug in Canada. There are Various submission types are there in Health Canada i.e., NDA, SNDA, ANDA, SANDA. In the present review article, we will discuss about the New Drug Submission and approval process in Canada. },
        keywords = {NDS, Canada Drug approval Process, Health Canada, Regulatory Body, New drug Submission and Approval Process, Pharmaceutical market},
        month = {},
        }